Literature DB >> 35383291

Exploring the future of research in the Tp53 field.

Arnold J Levine1.   

Abstract

Entities:  

Year:  2022        PMID： 35383291      PMCID： PMC9090764          DOI： 10.1038/s41418-022-00986-1

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN： 1350-9047            Impact factor:   12.067


× No keyword cloud information.
  10 in total

Review 1.  Of the many cellular responses activated by TP53, which ones are critical for tumour suppression?

Authors:  Gemma L Kelly; Andreas Strasser; Annabella F Thomas
Journal:  Cell Death Differ       Date:  2022-04-08       Impact factor: 12.067

2.  Higher-than-expected population prevalence of potentially pathogenic germline TP53 variants in individuals unselected for cancer history.

Authors:  Kelvin César de Andrade; Lisa Mirabello; Douglas R Stewart; Eric Karlins; Roelof Koster; Mingyi Wang; Susan M Gapstur; Mia M Gaudet; Neal D Freedman; Maria Teresa Landi; Nathanaël Lemonnier; Pierre Hainaut; Sharon A Savage; Maria Isabel Achatz
Journal:  Hum Mutat       Date:  2017-09-21       Impact factor: 4.878

3.  Targeting the P53 Protein for Cancer Therapies: The Translational Impact of P53 Research.

Authors:  Arnold J Levine
Journal:  Cancer Res       Date:  2022-02-01       Impact factor: 12.701

Review 4.  Should mutant TP53 be targeted for cancer therapy?

Authors:  Andreas Strasser; Gemma L Kelly; Zilu Wang
Journal:  Cell Death Differ       Date:  2022-03-24       Impact factor: 12.067

5.  p53 modifications: exquisite decorations of the powerful guardian.

Authors:  Yanqing Liu; Omid Tavana; Wei Gu
Journal:  J Mol Cell Biol       Date:  2019-07-19       Impact factor: 6.216

Review 6.  Structural diversity of p63 and p73 isoforms.

Authors:  Christian Osterburg; Volker Dötsch
Journal:  Cell Death Differ       Date:  2022-03-21       Impact factor: 12.067

Review 7.  Mutant p53: it's not all one and the same.

Authors:  Margaret C Kennedy; Scott W Lowe
Journal:  Cell Death Differ       Date:  2022-03-31       Impact factor: 12.067

Review 8.  p53, cancer and the immune response.

Authors:  Julianna Blagih; Michael D Buck; Karen H Vousden
Journal:  J Cell Sci       Date:  2020-03-06       Impact factor: 5.285

Review 9.  Spontaneous and inherited TP53 genetic alterations.

Authors:  Arnold J Levine
Journal:  Oncogene       Date:  2021-08-13       Impact factor: 9.867
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.